Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting is a research paper published in Inflammatory Bowel Diseases (2022). On theSindex it has a DataRank of 0.505. It has been cited 28 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.505
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: K23KD111995-01A1
NIDDK NIH HHS
Grant: K23 DK111995
National Institutes of Health
Grant: 5K23DK111995-02
Assessing Predictors of Response to Anti-Tumor Necrosis Alpha Therapy in Early Crohns Disease
FWCI
4.54
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals